国产三抗新药首次公布临床结果

新浪医药
Nov 17, 2025

2025 年美国血液学会(ASH)年会将于当地时间 12 月 6 日到 12 月 9 日在美国佛罗里达州奥兰多市召开,目前常规摘要已经公布。齐鲁制药将在本次会议上首次公布下一代GPRC5D×BCMA×CD3三抗 QLS4131在复发或难治性多发性骨髓瘤(RRMM)患者中首次人体试验的初步研究结果。截图来源:ASH 官网QLS4131 是一款 BCMA/GPRC5D/CD3 三抗。临床前数据显示,与...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10